Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Carbamazepine
Drug ID BADD_D00356
Description Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]
Indications and Usage For the treatment of epilepsy and pain associated with true trigeminal neuralgia.
Marketing Status Prescription; Discontinued
ATC Code N03AF01
DrugBank ID DB00564
KEGG ID D00252
MeSH ID D002220
PubChem ID 2554
TTD Drug ID D04MSM
NDC Product Code 60687-594; 51672-4123; 70518-3174; 67296-1637; 0781-5988; 68094-008; 0078-0509; 16571-682; 68084-561; 50090-5740; 68084-562; 0121-1894; 75834-221; 63629-8753; 70518-0181; 0904-7116; 68788-7825; 71335-0461; 51672-4047; 60505-2807; 60429-032; 50090-0384; 68071-4313; 0904-6172; 48087-0051; 70518-1769; 75834-220; 70518-2456; 68382-555; 42419-014; 29033-004; 30698-421; 16571-681; 16714-063; 0781-5987; 38779-0114; 50268-171; 70518-1433; 72189-157; 51927-2176; 54092-172; 13668-268; 51672-4124; 71930-072; 51552-0653; 70518-3176; 54092-173; 0615-3505; 0078-0508; 51672-4149; 35561-355; 65344-0028; 70518-1545; 0093-0090; 16714-065; 68382-557; 43063-328; 68788-7210; 0078-0512; 71930-073; 70518-3335; 68382-556; 71335-1730; 29033-019; 67386-621; 70518-3146; 70518-1436; 0781-8016; 51407-215; 49452-1705; 0832-6023; 43353-953; 70518-3266; 16714-064; 55154-1396; 76003-0251; 0078-0511; 0615-8125; 66993-409; 60505-2805; 60429-934; 51672-4150; 0093-0778; 17856-0407; 72664-218; 66993-407; 70518-2426; 51672-4151; 0832-6024; 63629-8255; 50090-2161; 70771-1469; 62512-0024; 70966-0020; 68094-007; 16571-680; 70518-2489; 60687-479; 70771-1470; 71205-025; 48087-0052; 35561-357; 51672-4005; 0121-1724; 13668-271; 60432-129; 71610-336; 60687-583; 63629-8743; 0121-0947; 70518-2841; 62991-1027; 35561-356; 0093-0109; 30698-419; 0904-6885; 70518-2653; 71930-074; 63552-060; 50090-4443; 63629-8721; 65372-1102; 71335-0691; 66993-408; 54092-171; 70771-1468; 63629-8720; 70518-2242; 0832-6022; 60505-0183; 60505-2806; 58118-0268; 0078-0510; 63629-8715; 51672-4041; 71335-0462; 50268-170; 29033-020; 0121-0862; 70518-0902; 50268-172; 0904-3854; 51672-4125; 30698-423
Synonyms Carbamazepine | Carbamazepine Acetate | Carbamazepine Dihydrate | Carbamazepine Hydrochloride | Carbamazepine L-Tartrate (4:1) | Carbamazepine Anhydrous | Carbamazepine Sulfate (2:1) | Carbazepin | Epitol | Finlepsin | Neurotol | Tegretol | Amizepine | Carbamazepine Phosphate
Chemical Information
Molecular Formula C15H12N2O
CAS Registry Number 298-46-4
SMILES C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Drug dependenceBifunctional epoxide hydrolase 2P34913T357348877250; 3146222; 8968658; 10380060
HepatotoxicityCytochrome P450 3A4P08684T378481575766; 8723729; 8347124
HypersensitivityEpoxide hydrolase 1P07099Not Available7503783; 7503784
Nephropathy toxicGlutathione hydrolase 1 proenzymeP19440Not Available8125216; 8457719; 1508841; 7785052; 15856183; 8494733; 8720036; 15223355
PorphyriaDelta-aminolevulinic acid dehydrataseQ5TJH2Not Available3181278; 6428897; 71507; 4067519; 3130256; 913061; 7120315; 463487; 4096716; 2500271; 6780356; 3813879; 2429498; 1165472; 6896622; 6800821
PorphyriaDelta-aminolevulinic acid dehydrataseP13716T205143181278; 6428897; 71507; 4067519; 3130256; 913061; 7120315; 463487; 4096716; 2500271; 6780356; 3813879; 2429498; 1165472; 6896622; 6800821
Renal impairmentBeta-2-microglobulinP61769T580803280573; 2679841; 6392147
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Adactyly15.11.07.016; 03.11.07.0160.001263%Not Available
Lumbar vertebral fracture15.08.05.007; 12.04.04.0070.000842%Not Available
Duodenal stenosis07.13.06.0050.000842%
Tongue biting07.14.01.013; 17.02.05.064; 12.01.09.0190.000842%Not Available
Cytomegalovirus test positive13.08.03.0140.001684%Not Available
Lip erosion07.05.01.0160.001263%Not Available
Brachycephaly15.11.02.004; 03.11.02.0040.000842%Not Available
Clostridium difficile infection11.02.02.009--Not Available
Anticonvulsant drug level above therapeutic13.17.01.0220.001263%Not Available
Lip injury12.01.09.016; 07.05.01.0170.000842%Not Available
Partial seizures with secondary generalisation17.12.03.0280.000842%Not Available
Anticonvulsant drug level below therapeutic13.17.01.0230.001684%Not Available
Cell death08.03.03.003; 14.11.02.0050.000842%Not Available
Anticonvulsant drug level decreased13.17.01.0240.005052%Not Available
Gastrointestinal oedema07.11.01.0120.000842%Not Available
Multi-organ disorder08.01.03.0740.000329%Not Available
Poor sucking reflex17.02.01.008; 18.04.04.0110.001684%Not Available
Sopor19.02.04.002; 17.02.04.0210.016417%Not Available
Psychogenic seizure19.24.01.0070.000842%Not Available
General physical condition abnormal13.15.01.0400.000842%Not Available
Lymphocyte stimulation test positive13.01.06.0560.002526%Not Available
Human herpes virus 6 serology positive13.08.03.0250.004631%Not Available
Foetal malformation18.03.02.016; 03.02.01.0120.000220%Not Available
Communication disorder19.19.01.0080.000842%Not Available
Congenital intestinal malformation07.11.04.008; 03.04.04.0030.000220%Not Available
Mycoplasma infection11.10.01.0020.000842%Not Available
Wrist deformity15.10.03.0100.000842%Not Available
Pyelocaliectasis20.01.06.0110.000842%Not Available
Grip strength decreased13.15.01.0410.001263%Not Available
Foaming at mouth17.02.05.056; 08.01.03.070; 07.05.05.0190.002105%Not Available
The 36th Page    First    Pre   36 37    Next   Last    Total 37 Pages